novidades científicas Novo

16:13 European Cardiovascular Disease Statistics 2017
10:47 CETP inhibitor meets primary endpoint in CV outcome study
9:54 Arrhythmias and devices
14:31 Clinically significant bleeding with low-dose rivaroxaban versus aspirin, in addition to P2Y12 inhibition, in acute coronary syndromes (GEMINI-ACS-1): a double-blind, multicentre, randomised trial
14:18 Rivaroxaban or Aspirin for Extended Treatment of Venous Thromboembolism

CARGA LÍPIDA E RISCO VASCULAR

26 Maio 2021

Carga Lípida e Risco Cardiovascular

ORADORES

Cristina Gavina

Carlos Rabaçal

José Pereira de Moura

António Ferreira

CARGA LÍPIDA E RISCO VASCULAR

Diagnóstico e avaliação prognóstica da doença cardíaca isquémica

25 Maio 2021
0

CARGA LÍPIDA E RISCO VASCULAR

Teste

27 Maio 2021
0

-->